Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

EHA 2020 | EHA 2020: what to keep an eye out for in MPNs

Srdan Verstovsek, MD, PhD, of the University of Texas MD Anderson Cancer Center, Houston, TX, discusses key developments in the treatment of myeloproliferative neoplasms (MPNs) presented at the 25th Annual European Hematology Association (EHA) conference. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).